Circulation Research, Vol 49, 316-325, Copyright © 1981 by American Heart Association

ARTICLES

Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis

NA Shaikh and E Downar

This study was performed to determine the early and delayed metabolic effects of myocardial ischemia on the major membrane phospholipids and to reassess the potential role of lysophospholipids in the genesis of malignant dysrhythmias induced by ischemia. Samples taken from in situ hearts before ant at various intervals up to 40 minutes after abrupt ligation of LAD were extracted by the classical Folch technique with modifications to avoid artifactual lysophospholipid production and losses. Following thin layer chromatography of lipid extracts, phospholipid fractions were quantified by phosphorus estimation and lysophospholipids by a more sensitive method employing gas liquid chromatography. The total phospholipid content with the exception of lysophospholipids remained essentially constant throughout the early phases of acute ischemia, but fell by 6 and 14% after 8 and 24 ours, respectively. At 8 minutes, lysophospholipid levels n ischemic myocardium were significantly increased by 60% compared to pre- occlusion controls in the ischemic zone and by 25% in post-occlusion controls. They changed little thereafter. The molecular species of lysophospholipids remained unchanged throughout the period of ischemia studied. The mole fraction of other phospholipids as well as their fatty acyl and aldehyde profiles also were unchanged. Despite significant elevations in lysophospholipids levels, their absolute quantities were very small (0.6% of total phospholipid P) and 15-fold smaller than that reported in vitro to simulate electrophysiological manifestation of ischemia. However, such small amounts in vivo, if produced in the microenvironment of certain membrane-bound enzymes along with acidosis, hypoxia, and fatty acids, could be potentially deleterious to cell functions.

This article has been cited by other articles:

				E. Kroger, R. Verreault, P.-H. Carmichael, J. Lindsay, P. Julien, E. Dewailly, P. Ayotte, and D. Laurin Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging Am. J. Clinical Nutrition, July 1, 2009; 90(1): 184 - 192. [Abstract] [Full Text] [PDF]

				M. Lucas, G. Asselin, C. Merette, M.-J. Poulin, and S. Dodin Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial Am. J. Clinical Nutrition, February 1, 2009; 89(2): 641 - 651. [Abstract] [Full Text] [PDF]

				I. Romieu, M. M. Tellez-Rojo, M. Lazo, A. Manzano-Patino, M. Cortez-Lugo, P. Julien, M. C. Belanger, M. Hernandez-Avila, and F. Holguin Omega-3 Fatty Acid Prevents Heart Rate Variability Reductions Associated with Particulate Matter Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1534 - 1540. [Abstract] [Full Text] [PDF]

				F. S. Apple, A. H.B. Wu, J. Mair, J. Ravkilde, M. Panteghini, J. Tate, F. Pagani, R. H. Christenson, M. Mockel, O. Danne, et al. Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome Clin. Chem., May 1, 2005; 51(5): 810 - 824. [Abstract] [Full Text] [PDF]

				N. Ortenblad, J. F. Young, N. Oksbjerg, J. H. Nielsen, and I. H. Lambert Reactive oxygen species are important mediators of taurine release from skeletal muscle cells Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1362 - C1373. [Abstract] [Full Text] [PDF]

				L. Li, I. Matsuoka, Y. Suzuki, Y. Watanabe, T. Ishibashi, K. Yokoyama, Y. Maruyama, and J. Kimura Inhibitory Effect of Fluvastatin on Lysophosphatidylcholine-Induced Nonselective Cation Current in Guinea Pig Ventricular Myocytes Mol. Pharmacol., September 1, 2002; 62(3): 602 - 607. [Abstract] [Full Text] [PDF]

				S. S. D. Nair, J. Leitch, J. Falconer, and M. L Garg Cardiac (n-3) Non-Esterified Fatty Acids Are Selectively Increased in Fish Oil-Fed Pigs following Myocardial Ischemia J. Nutr., August 1, 1999; 129(8): 1518 - 1523. [Abstract] [Full Text]

				M. Chen, C.-Y. Xiao, H. Hashizume, and Y. Abiko Phospholipase A2 is not responsible for lysophosphatidylcholine-induced damage in cardiomyocytes Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1782 - H1787. [Abstract] [Full Text] [PDF]

				J. W. Kinn and R. J. Bache Effect of Platelet Activation on Coronary Collateral Blood Flow Circulation, October 6, 1998; 98(14): 1431 - 1437. [Abstract] [Full Text] [PDF]

				R. A. Caldwell and C. M. Baumgarten Plasmalogen-Derived Lysolipid Induces a Depolarizing Cation Current in Rabbit Ventricular Myocytes Circ. Res., September 7, 1998; 83(5): 533 - 540. [Abstract] [Full Text] [PDF]

				L. Yu, T. Netticadan, Y.-J. Xu, V. Panagia, and N. S. Dhalla Mechanisms of Lysophosphatidylcholine-Induced Increase in Intracellular Calcium in Rat Cardiomyocytes J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 1 - 8. [Abstract] [Full Text]

				S. Yamaguchi, M. Tamagawa, N. Nakajima, and Haruaki Nakaya Selective impairment of HCO3--dependent pHi regulation by lysophosphatidylcholine in guinea pig ventricular myocardium Cardiovasc Res, January 1, 1998; 37(1): 179 - 186. [Abstract] [Full Text] [PDF]

				A. Wang, R. Loo, Z. Chen, and E. A. Dennis Regiospecificity and Catalytic Triad of Lysophospholipase I J. Biol. Chem., August 29, 1997; 272(35): 22030 - 22036. [Abstract] [Full Text] [PDF]